Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy

Advancements in chimeric antigen receptor engineered T-cell (CAR-T) therapy have revolutionized treatment for several cancer types over the past decade. Despite this success, obstacles including the high price tag, manufacturing complexity, and treatment-associated toxicities have limited the broad...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilgour, Marisa K., Bastin, Donald J., Lee, Seung-Hwan, Ardolino, Michele, McComb, Scott, Visram, Alissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187144/
https://www.ncbi.nlm.nih.gov/pubmed/37205115
http://dx.doi.org/10.3389/fimmu.2023.1166038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187144/
https://www.ncbi.nlm.nih.gov/pubmed/37205115
http://dx.doi.org/10.3389/fimmu.2023.1166038

Ejemplares similares